227 related articles for article (PubMed ID: 23122536)
21. Potential Impact of the Z0011 Trial on the Omission of Axillary Dissection: A Retrospective Cohort Study.
Shinzato JY; Serra KP; Eugeni C; Cabello C; Cardoso-Filho C; Zeferino LC
Rev Bras Ginecol Obstet; 2021 Apr; 43(4):297-303. PubMed ID: 33784760
[TBL] [Abstract][Full Text] [Related]
22. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
[TBL] [Abstract][Full Text] [Related]
23. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.
Chung A; Gangi A; Mirocha J; Giuliano A
Ann Surg Oncol; 2015 Apr; 22(4):1128-32. PubMed ID: 25300606
[TBL] [Abstract][Full Text] [Related]
24. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer.
Yao K; Liederbach E; Pesce C; Wang CH; Winchester DJ
J Am Coll Surg; 2015 Jul; 221(1):71-81. PubMed ID: 25899731
[TBL] [Abstract][Full Text] [Related]
25. Size of Extranodal Extension on Sentinel Lymph Node Dissection in the American College of Surgeons Oncology Group Z0011 Trial Era.
Choi AH; Blount S; Perez MN; Chavez de Paz CE; Rodriguez SA; Surrusco M; Garberoglio CA; Lum SS; Senthil M
JAMA Surg; 2015 Dec; 150(12):1141-8. PubMed ID: 26331347
[TBL] [Abstract][Full Text] [Related]
26. National Trend of Axillary Management in Clinical T3/T4 N0 Patients Having Breast Conserving Therapy.
Morris MC; Lee TC; Johnston ME; Hanseman D; Lewis JD; Shaughnessy EA; Reyna C
J Surg Res; 2020 Nov; 255():361-370. PubMed ID: 32599456
[TBL] [Abstract][Full Text] [Related]
27. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.
Caudle AS; Hunt KK; Tucker SL; Hoffman K; Gainer SM; Lucci A; Kuerer HM; Meric-Bernstam F; Shah R; Babiera GV; Sahin AA; Mittendorf EA
Ann Surg Oncol; 2012 Oct; 19(10):3144-51. PubMed ID: 22847123
[TBL] [Abstract][Full Text] [Related]
28. Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
Riedel F; Heil J; Feisst M; Moderow M; von Au A; Domschke C; Michel L; Schaefgen B; Golatta M; Hennigs A
Breast Cancer Res Treat; 2020 Nov; 184(2):627-636. PubMed ID: 32816190
[TBL] [Abstract][Full Text] [Related]
29. A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery.
Kittaka N; Tokui R; Ota C; Hashimoto Y; Motomura K; Ishitobi M; Nakayama T; Tamaki Y
Int J Clin Oncol; 2018 Oct; 23(5):860-866. PubMed ID: 29789974
[TBL] [Abstract][Full Text] [Related]
30. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
31. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
32. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.
Posther KE; McCall LM; Blumencranz PW; Burak WE; Beitsch PD; Hansen NM; Morrow M; Wilke LG; Herndon JE; Hunt KK; Giuliano AE
Ann Surg; 2005 Oct; 242(4):593-9; discussion 599-602. PubMed ID: 16192820
[TBL] [Abstract][Full Text] [Related]
33. The current application of ACOSOG Z0011 trial results: Is further implementation of sentinel lymph node intra-operative histopathological examination mandatory in breast cancer patients - a single-centre analysis.
Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Glowacka-Mrotek I; Sowa M; Biedka M; Kolacinska A
Neoplasma; 2018 Mar; 65(3):449-454. PubMed ID: 29788732
[TBL] [Abstract][Full Text] [Related]
34. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
[TBL] [Abstract][Full Text] [Related]
35. Choice of Mastectomy May Increase the Extent of Axillary Surgery in Women with Breast Cancer.
Zaveri S; Romanoff A; Hirt L; Thompson L; Pisapati KV; Weltz C; Schmidt H; Port E
Am Surg; 2022 Nov; 88(11):2686-2694. PubMed ID: 35081002
[TBL] [Abstract][Full Text] [Related]
36. Adherence Rate to Alliance for Clinical Trials in Oncology Z0011 Trial Based on Breast Cancer Subtype.
Maramara T; Hsieh MC; Janjua M; Li T; Wu XC; Williams M; Shoup M; Chu QD
J Am Coll Surg; 2024 Apr; 238(4):656-667. PubMed ID: 38193547
[TBL] [Abstract][Full Text] [Related]
37. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
Ong CT; Thomas SM; Blitzblau RC; Fayanju OM; Park TS; Plichta JK; Rosenberger LH; Hyslop T; Shelley Hwang E; Greenup RA
Ann Surg Oncol; 2017 Nov; 24(12):3559-3566. PubMed ID: 28879416
[TBL] [Abstract][Full Text] [Related]
38. Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.
Verheuvel NC; Voogd AC; Tjan-Heijnen VC; Roumen RM
Eur J Surg Oncol; 2016 Aug; 42(8):1162-8. PubMed ID: 27265036
[TBL] [Abstract][Full Text] [Related]
39. Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed?
Subhedar P; Stempel M; Eaton A; Morrow M; Gemignani ML
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S470-5. PubMed ID: 26178759
[TBL] [Abstract][Full Text] [Related]
40. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
